Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes Director gave up 880 shares (to pay taxes)
  2. 4 Shares withheld for taxes Principal Accounting Officer gave up 219 shares (to pay taxes)
  3. 4 Open-market sale Principal Accounting Officer sold 2,427 shares at $53.37 ($129,529)
  4. 4 Shares withheld for taxes Principal Accounting Officer gave up 1,163 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 819 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 886 shares (to pay taxes)
  8. 4 Shares withheld for taxes Director gave up 2,534 shares (to pay taxes)
  9. 4 Open-market sale Chief Medical Officer sold 7,100 shares at $50.16 ($356,112)
  10. 4 Open-market sale Chief Medical Officer sold 621 shares at $50.02 ($31,063)
  11. 4 Open-market sale Chief Medical Officer sold 49,638 shares at an average $50.08 ($2,485,989)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Principal Accounting Officer sold 2,950 shares at $50.09 ($147,766)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Chief Executive Officer bought 40,322 shares at $31.00 ($1,249,982)
  18. 4 Open-market buy Director bought 8,064 shares at $31.00 ($249,984)
  19. 4 Open-market buy 10% owner bought 403,225 shares at $31.00 ($12,499,975)
  20. 4 Gift Director gave 5,000 shares (gift)

Page 17 of 38 · 758 filings